S.PNEUMONIAH.INFLUENZAECHL.PNEUMONIAN.MENINGITIS RG MULTIPLEX RNA Detection Qualitative Test
Welcome to the DNA Labs UAE blog! Today, we will be discussing the S.PNEUMONIAH.INFLUENZAECHL.PNEUMONIAN.MENINGITIS RG MULTIPLEX RNA Detection Qualitative Test.
Test Details
The S.PNEUMONIAH.INFLUENZAECHL.PNEUMONIAN.MENINGITIS RG MULTIPLEX RNA Detection Qualitative Test is a diagnostic test used to detect the presence of RNA from Streptococcus pneumoniae, Haemophilus influenzae, Chlamydia pneumoniae, and Neisseria meningitidis in a patient’s sample. This test is typically performed on respiratory samples, such as sputum or nasopharyngeal swabs, to identify the specific pathogens causing pneumonia, influenza, or meningitis.
The test utilizes a molecular technique called reverse transcription polymerase chain reaction (RT-PCR) to amplify and detect the RNA of these bacteria in the sample. The presence of RNA from any of these pathogens indicates an active infection. This qualitative test provides a yes or no answer regarding the presence of these pathogens in the patient’s sample, helping healthcare providers make a diagnosis and guide appropriate treatment.
Test Components and Price
The S.PNEUMONIAH.INFLUENZAECHL.PNEUMONIAN.MENINGITIS RG MULTIPLEX RNA Detection Qualitative Test is priced at 1700.0 AED. The test can be conducted on various sample conditions including blood, nasopharyngeal secretions, nasopharyngeal swabs, C.S.F., bronchial swabs, bronchial lavage, etc.
Report Delivery
The report for this test will be delivered on the 3rd working day via email within 36 hours. Alternatively, it can also be obtained over the phone within 24 hours.
Method and Test Type
The S.PNEUMONIAH.INFLUENZAECHL.PNEUMONIAN.MENINGITIS RG MULTIPLEX RNA Detection Qualitative Test is conducted using the Real Time PCR method. It falls under the category of viral tests and is performed by a physician in the Genetics department.
Pre Test Information
Prior to conducting the S.PNEUMONIAH.INFLUENZAECHL.PNEUMONIAN.MENINGITIS RG MULTIPLEX RNA Detection Qualitative Test, patients are required to sign a consent document and provide any relevant clinical history.
The clinical history should include information related to S.PNEUMONIA, H.INFLUENZAE, CHL.PNEUMONIA, and N.MENINGITIS RG MULTIPLEX (RNA Detection) Qualitative Test.
By providing this information, healthcare providers can better understand the patient’s condition and make more accurate diagnoses.
Thank you for reading our blog post about the S.PNEUMONIAH.INFLUENZAECHL.PNEUMONIAN.MENINGITIS RG MULTIPLEX RNA Detection Qualitative Test. If you have any further questions or would like to schedule an appointment, please contact DNA Labs UAE.
Test Name | S.PNEUMONIAH.INFLUENZAECHL.PNEUMONIAN.MENI NGITIS RG MULTIPLEX RNA Detection Qualitative Test |
---|---|
Components | |
Price | 1700.0 AED |
Sample Condition | Blood, nasopharyngeal secretions, nasopharyngeal swabs, C.S.F. Bronchial swabs, Bronchial lavage etc |
Report Delivery | 3rd Working Day Email:-36 hours.On phone: 24 hours |
Method | Real Time PCR |
Test type | Viral |
Doctor | Physician |
Test Department: | Genetics |
Pre Test Information | Need to sign Consent document and bring any clinical history of patient forS.PNEUMONIA,H.INFLUENZAE,CHL.PNEUMONIA,N.MENI NGITIS RG MULTIPLEX (RNA Detection) QualitativeTest |
Test Details |
The S.PNEUMONIA, H.INFLUENZAE, CHL.PNEUMONIA, N.MENINGITIS RG MULTIPLEX (RNA Detection) Qualitative Test is a diagnostic test used to detect the presence of RNA from Streptococcus pneumoniae, Haemophilus influenzae, Chlamydia pneumoniae, and Neisseria meningitidis in a patient’s sample. This test is typically performed on respiratory samples, such as sputum or nasopharyngeal swabs, to identify the specific pathogens causing pneumonia, influenza, or meningitis. The test uses a molecular technique called reverse transcription polymerase chain reaction (RT-PCR) to amplify and detect the RNA of these bacteria in the sample. The presence of RNA from any of these pathogens indicates an active infection. This qualitative test provides a yes or no answer regarding the presence of these pathogens in the patient’s sample, helping healthcare providers make a diagnosis and guide appropriate treatment. |